Krensavage Asset Management, LLC Long-Term Concentrated

Location: New York, NY

CIK: 0001609251 · Show all filings

Period: Q4 2025 (← Previous) (Next →)

Filing Date: Feb 18, 2026

Total Value: $283M

Holdings (18)

UTHR UNITED THERAPEUTICS CORP 15.7%

Value $44.48M Shares 91,282 Est. Cost $146.00 Unrealized +219.0%

ENTA ENANTA PHARMACEUTICALS INC 15.4%

Value $43.63M Shares 2,766,390 Est. Cost $19.93 Unrealized -36.3%

BMRN BIOMARIN PHARMACEUTICAL INC 11.0%

Value $31.19M Shares 524,786 Est. Cost $56.56 Unrealized -3.8%

JAZZ JAZZ PHARMACEUTICALS PLC 10.1%

Value $28.53M Shares 167,816 Est. Cost $117.78 Unrealized +30.2%

EXEL EXELIXIS INC 7.6%

Value $21.63M Shares 493,526 Est. Cost $19.77 Unrealized +109.3%

— AVADEL PHARMACEUTICALS 6.5%

Value $18.44M Shares 855,860 Est. Cost $7.83 Unrealized —

SNY SANOFI-ADR 5.5%

Value $15.7M Shares 323,946 Est. Cost $48.35 Unrealized —

SUPN SUPERNUS PHARMACEUTICALS INC 5.5%

Value $15.58M Shares 313,499 Est. Cost $35.15 Unrealized +38.3%

CAH CARDINAL HEALTH INC 5.4%

Value $15.15M Shares 73,745 Est. Cost $56.53 Unrealized +232.1%

— INDIVIOR PLC 4.3%

Value $12.18M Shares 339,532 Est. Cost $10.39 Unrealized —

VNDA VANDA PHARMACEUTICALS INC 3.7%

Value $10.41M Shares 1,180,388 Est. Cost $4.75 Unrealized +15.8%

BNTX BIONTECH SE-ADR 3.3%

Value $9.475M Shares 99,523 Est. Cost $92.42 Unrealized —

GSK GSK PLC-SPON ADR 1.7%

Value $4.744M Shares 96,729 Est. Cost $38.74 Unrealized —

RARE ULTRAGENYX PHARMACEUTICAL IN 1.2%

Value $3.442M Shares 149,634 Est. Cost $32.88 Unrealized 0.0%

REGN REGENERON PHARMACEUTICALS 1.1%

Value $3.087M Shares 4,000 Est. Cost $556.12 Unrealized +22.0%

ALKS ALKERMES PLC 1.1%

Value $3.017M Shares 107,822 Est. Cost $18.83 Unrealized +59.1%

BIIB BIOGEN INC 0.6%

Value $1.76M Shares 10,000 Est. Cost $135.17 Unrealized +20.9%

EOLS EVOLUS INC 0.2%

Value $665K Shares 100,000 Est. Cost $7.80 Unrealized -13.1%

Ticker	Issuer	Shares	Value	%	Est. Cost	Unrealized	Class	CUSIP
UTHR	UNITED THERAPEUTICS CORP	91,282	$44.48M	15.7%	$146.00	+219.0%	—	91307C102
ENTA	ENANTA PHARMACEUTICALS INC	2,766,390	$43.63M	15.4%	$19.93	-36.3%	—	29251M106
BMRN	BIOMARIN PHARMACEUTICAL INC	524,786	$31.19M	11.0%	$56.56	-3.8%	—	09061G101
JAZZ	JAZZ PHARMACEUTICALS PLC	167,816	$28.53M	10.1%	$117.78	+30.2%	—	G50871105
EXEL	EXELIXIS INC	493,526	$21.63M	7.6%	$19.77	+109.3%	—	30161Q104
—	AVADEL PHARMACEUTICALS	855,860	$18.44M	6.5%	$7.83	—	—	G29687103
SNY	SANOFI-ADR	323,946	$15.7M	5.5%	$48.35	—	—	80105N105
SUPN	SUPERNUS PHARMACEUTICALS INC	313,499	$15.58M	5.5%	$35.15	+38.3%	—	868459108
CAH	CARDINAL HEALTH INC	73,745	$15.15M	5.4%	$56.53	+232.1%	—	14149Y108
—	INDIVIOR PLC	339,532	$12.18M	4.3%	$10.39	—	—	G4766E116
VNDA	VANDA PHARMACEUTICALS INC	1,180,388	$10.41M	3.7%	$4.75	+15.8%	—	921659108
BNTX	BIONTECH SE-ADR	99,523	$9.475M	3.3%	$92.42	—	—	09075V102
GSK	GSK PLC-SPON ADR	96,729	$4.744M	1.7%	$38.74	—	—	37733W204
RARE	ULTRAGENYX PHARMACEUTICAL IN	149,634	$3.442M	1.2%	$32.88	0.0%	—	90400D108
REGN	REGENERON PHARMACEUTICALS	4,000	$3.087M	1.1%	$556.12	+22.0%	—	75886F107
ALKS	ALKERMES PLC	107,822	$3.017M	1.1%	$18.83	+59.1%	—	G01767105
BIIB	BIOGEN INC	10,000	$1.76M	0.6%	$135.17	+20.9%	—	09062X103
EOLS	EVOLUS INC	100,000	$665K	0.2%	$7.80	-13.1%	—	30052C107